# Contact Get PT-141: The Bremelanotide Research Digest

> Contact Get PT-141, an independent editorial digest of the PT-141 (bremelanotide) research literature. Editorial correspondence only — not medical advice, not a vendor.

For corrections, source suggestions, and editorial questions about the PT-141 research digest. We do not provide medical advice or sell anything.

## Editorial correspondence

Use the form below for editorial matters: a correction to a summary, a peer-reviewed study you think we should cite, or a question about how we read a finding. We welcome pointers to studies we have missed, especially newer work on the central melanocortin mechanism or the ongoing PDE-5-combination program.

What this channel is not: it is not a medical service. We cannot answer questions about whether PT-141 is right for any individual, cannot recommend a dose, and cannot provide clinical guidance. Those are matters for a qualified healthcare professional with access to a person's full history.

## What we cannot help with

We do not sell, source, or supply PT-141 or bremelanotide, and we cannot help you obtain either. We hold no inventory, list no vendors, and quote no prices. Requests to buy, locate a supplier, or arrange access are outside what this editorial project does and will not be answered.

If your message concerns the published research — its accuracy, its sources, or its interpretation — that is exactly what we want to hear, and we will do our best to respond.

---

The PT-141 (bremelanotide) record printed at billboard scale — the approved-for-women-only indication, the off-label male research, and the nausea-led tolerability set out in plain sight and cited to source; a poster of the evidence, with no clinic behind it and nothing here dispensed or sold.